Methylphenidate: Difference between revisions
From Pharmacopedia
More actions
| [checked revision] | [checked revision] |
MDElliottMD (talk | contribs) Created page with "{{MedTemplate | generic = Methylphenidate | brand = Ritalin, Ritalin LA, Concerta, Metadate CD, Daytrana, Quillivant XR | structure = Methylphenidate.svg | classes = Psychostimulant, CNS stimulant, NDRI | mechanism = Norepinephrine–dopamine reuptake inhibition (DAT, NET) | uses = ADHD, narcolepsy | formula = C<sub>14</sub>H<sub>19</sub>NO<sub>2</sub> | routes = Oral, transdermal | onset..." |
MDElliottMD (talk | contribs) Pharmacopedia: remove contraindications parameter |
||
| Line 48: | Line 48: | ||
* '''Stereotyped behaviors''' — rare at therapeutic doses | * '''Stereotyped behaviors''' — rare at therapeutic doses | ||
* '''Skin reactions''' — chemical leukoderma (permanent depigmentation) at Daytrana patch application sites | * '''Skin reactions''' — chemical leukoderma (permanent depigmentation) at Daytrana patch application sites | ||
| interactions = * '''MAOIs''' (phenelzine, tranylcypromine, selegiline, linezolid) — hypertensive crisis risk; contraindicated | | interactions = * '''MAOIs''' (phenelzine, tranylcypromine, selegiline, linezolid) — hypertensive crisis risk; contraindicated | ||
* '''Tricyclic antidepressants''' — methylphenidate may elevate TCA plasma levels; additive cardiovascular effects | * '''Tricyclic antidepressants''' — methylphenidate may elevate TCA plasma levels; additive cardiovascular effects | ||